Why Isn't NVIDIA Stock at $300 While Other Semiconductor Stocks Rally?

NVIDIA closed at $199.64, up just 7% year to date and well behind peers such as Marvell (+95%), Micron (+69%), AMD (+43%), TSM (+26%), and Broadcom (+22%). The article highlights China-related headwinds, with Q1 FY27 guidance excluding China data center revenue after $4.5 billion in H20 inventory charges, plus aggressive insider selling by senior executives in March. While long-term AI demand remains intact, near-term upside to $300 is portrayed as unlikely given the $268.61 consensus target and only 2% Polymarket odds of closing above $230 by month-end.

Analysis

The key market signal is not that NVIDIA is “broken,” but that AI capex is being re-priced from a single-name monopoly into a basket trade. That usually compresses the multiple of the incumbent while expanding the revenue visibility of second-order beneficiaries: custom silicon, memory, and networking names can keep re-rating even if NVIDIA’s own multiple stays pinned. In other words, the marginal dollar of AI spend is increasingly flowing to the picks-and-shovels layer, which is structurally better for peers with smaller bases and worse for the largest index-weighted beneficiary.

The bigger second-order issue is duration. NVIDIA can still compound fundamentals, but at a ~$5T scale the stock now needs both earnings acceleration and multiple expansion to move meaningfully higher; that creates an asymmetry where good quarters may only hold the line unless there is a clear step-up in forward revisions. Export-control friction adds another layer: any incremental upside from product ramps has to offset a geopolitically constrained revenue pool, which makes the stock more sensitive to guidance language than to headline beats.

The near-term catalyst set is binary: if management can convince the market that Blackwell Ultra and Vera Rubin create a 2026–27 demand air pocket and improve mix enough to defend margins, the lagging stock can catch up fast. If not, the rotation into peers likely persists for months, because investors have found multiple ways to express AI without paying the “platform premium” on NVIDIA. That makes the risk/reward for new longs less attractive than for relative-value or options structures.

The contrarian miss is that a weaker stock can actually be healthy here: it reduces crowded positioning and may be setting up for a sharper rebound if analyst targets start inching up after the next call. But absent a material revision cycle, the market is telling us the AI trade is broader than NVIDIA now, and breadth generally beats concentration at this stage of a capex supercycle.

Key Decisions for Investors

• Stay long MRVL/MU/AVGO over NVDA on a 1-3 month horizon: these names have cleaner relative upside because they are still in the multiple-expansion phase of the AI trade, while NVDA is in the prove-it phase.
• Initiate a relative-value pair: long AVGO / short NVDA, sized for earnings-season volatility. Thesis: AVGO has a better path to incremental estimate revisions from custom silicon and networking exposure, while NVDA is more likely to trade range-bound unless forward guidance materially improves.
• Sell near-dated NVDA upside via call spreads rather than outright long equity. Example structure: buy stock only on a pullback; otherwise use 1-2 month call spreads to express limited upside to a possible target revision, with defined premium at risk if rotation continues.
• If holding NVDA, hedge with a partial short in AMD or MRVL only on strength, not weakness. The goal is to isolate single-name beta from the broader AI basket rotation while preserving upside if NVIDIA reasserts leadership on the next print.
• Watch for a post-earnings revision window: if sell-side targets start moving above the current consensus over the next 2-6 weeks, cover short relative-value hedges quickly; if not, treat any rally toward prior highs as a trimming opportunity.